Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International



Home > Directory > Medicine and health > Diasome Pharmaceuticals, Inc.

Diasome Pharmaceuticals, Inc.

Diasome is developing Oral HDV-Insulin, a nanotechnology-based cell targeting system for the improved treatment of diabetes mellitus. Diasome's therapies have been tested in more than 100 subjects to date. The Company is preparing to conduct longer term clinical trials in 2008 after having held an end of Phase II meeting with the FDA in 2007.

Website

625 Ridge Pike, Building E, Suite 402
Conshohocken, PA 19428 USA
610-834-2700

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project